Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |